Stock listing
Arrowhead Pharmaceuticals, Inc.
- Ticker
- BMV:ARWR
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BMV
- Currency
- MXN
About Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. is a public company traded under the ticker ARWR in the American market. Arrowhead focuses on developing innovative medicines using its proprietary RNA-targeted technology platform.
Latest news from Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals Granted Entry in the FDA STAR Pilot Program for Plozasiran in Severe Hypertriglyceridemia
Oct 7, 2026
Arrowhead Pharmaceuticals to Host a Webinar with Interim Clinical Data from a Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer’s Disease and Other Tauopathies
Sep 29, 2026
Arrowhead Pharmaceuticals Announces Interim Topline Clinical Data for the First Dual-Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia
Sep 15, 2026
Arrowhead Pharmaceuticals to Participate in Upcoming September 2026 Investor Conferences
Sep 3, 2026